Opioids Market Size & Forecast Report, 2014 - 2025

Report ID: MN17617095  |  Published: March 2018  |  No of Pages: 113
Format: Electronic (PDF)  |  Industry: Pharmaceuticals

The global Opioids Market is anticipated to reach USD 34.96 billion by 2025. Opioids are drugs that act on the Nerve system to relieve pain. Opioids imply psychoactive compounds that can be made in a laboratory or occur naturally. Opioids generally act as a pain reliever and it is safe when taken for a small duration of time; that too, as per doctor’s prescription. However, when opioids are taken in high quantity it leads to the risk of mortality and dependence in patients. To treat severe and moderate pain opioids are mainly used.

In addition, the prevalence of disease situations with long-lasting pain, such as cancer, arthritis, fibromyalgia, and lower back pain is propelling the market. Significant increases in road accidents and trauma combined with repeatedly growing cases of surgical methods are driving the demand for opioid-based pain management solutions. On the other hand, the legalization and emergence of cannabis as a substitute for opioids obstruct the development of the opioids market and it is anticipated to grow at a significant CAGR of 4.8% in the upcoming period as the scope, product types, and applications are increasing across the globe.

The opioids Market may be explored by Product Outlook, applications, dosage forms, and geography. Opioids Market may be explored by Product Outlook as Immediate-Release/Short-Acting, could explore as (Codeine, Opioid, Oxycodone, Hydrocodone, Propoxyphene, Fentanyl, Hydroxymorphone, Morphine, Oxymorphone, Other IR), Extended-Release/Long-Acting Opioid could explore as (Methadone, Oxycodone, Fentanyl, Morphine, Oxymorphone, Hydromorphone, Tapentadol, Hydrocodone, Buprenorphine, Other ER).

The “Extended-release/Long-Acting Opioid” segment dominated the market in 2016 and is anticipated to maintain its dominance by 2025 due to factors such as the growth of innovative dose distributors such as high usage of these constituents for chronic pain organization and transdermal patches. The profits share of immediate-release opioids, comprising morphine, codeine, oxymorphone, and hydromorphone, is anticipated to decline due to frequent product recalls, and severe adverse effects.

Opioids Market may be explored by Applications as Pain Relief, (Cancer pain Low-back pain, Orthopedic, Fibromyalgia, Neuropathic pain, Postoperative pain management,), Cough Suppression, Deaddiction, Diarrhea Suppression, and Anesthesia. The “pain relief” segment dominated the market in 2016 and it is anticipated to maintain its dominance by 2025 due to factors such as the growth of combination drug therapies that deliver improved synergistic outcomes and are harmless. “Anesthesia” is anticipated to be the fastest rising segment throughout the upcoming period owing to factors such as high and safe drug effectiveness. The market may be explored by dosage forms like liquids, lozenges, transdermal patches, and pills.

North America accounted for the major share of the global Opioids Industry and will continue to rule the roost in the forecast period due to the increasing aged populace with terminal circumstances such as rheumatoid arthritis. Moreover, the growing acceptance of opioids for pain management related to injury and trauma in chronic and severe disabling diseases and cases of post-surgical pain is propelling market development in North America. Furthermore, North America is followed by Asia-Pacific and it is anticipated to witness the highest development in the years to come.

Some of the key players that fuel the growth of the Opioids Market include Johnson & Johnson Services, Inc., Purdue Pharma, QRxpharma limited, Pfizer, Inc., Endo Pharmaceuticals Inc., Mylan N.V., and AbbVie Inc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures to boost the inorganic growth of the industry.

Market Segment:

Opioids Product Outlook (Revenue, USD Billion, 2014 - 2025)
    • Immediate-Release/Short-Acting Opioid
        • Codeine
        • Oxycodone
        • Hydrocodone
        • Fentanyl
        • Morphine
        • Hydroxymorphone
        • Oxymorphone
        • Propoxyphene
        • Other IR
    • Extended-Release/Long-Acting Opioid
        • Oxycodone
        • Hydrocodone
        • Methadone
        • Fentanyl
        • Morphine
        • Oxymorphone
        • Tapentadol
        • Buprenorphine
        • Hydromorphone
        • Other ER

Opioids Application Outlook (Revenue, USD Billion, 2014 - 2025)
    • Pain Relief
        • Cancer pain
        • Postoperative pain management
        • Low-back pain
        • Orthopedic
        • Neuropathic pain
        • Fibromyalgia
    • Anesthesia
    • Cough Suppression
    • Diarrhea Suppression
    • Deaddiction

Opioids Regional Outlook (Revenue, USD Billion, 2014 - 2025)
    • North America
            • the U.S.
            • Canada
    • Europe
        • the U.K.
        • Germany
    • the Asia Pacific
        • Japan
        • China
        • India
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
Connect With Expert
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service

Get a Free Sample

FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...